Karl A. Nath, MBChB, Editor-in-Chief of Mayo Clinic Proceedings, discusses the Editor's Choice and Highlights articles appearing in the April 2019 issue.
These include:
“3023 Mayo Clinic Patients With Myeloproliferative Neoplasms: Risk-Stratified Comparison of Survival and Outcomes Data Among Disease Subgroups,”
by Dr Natasha Szuber and colleagues;
“Fluoroscopically Guided vs Landmark-Guided Sacroiliac Joint Injections: A Randomized Controlled Study,”
by Dr Steven P. Cohen and colleagues;
“Decisions to Withdraw Extracorporeal Membrane Oxygenation Support: Patient Characteristics and Ethical Considerations,” Dr Erin S. DeMartino and colleagues; and
“Association of Muscular Strength and Incidence of Type 2 Diabetes,”
Ms Yuehan Wang and colleagues.
Supplemental Online Material
- /cms/asset/8aa43041-c414-4aa9-ac57-573ed906908a/mmc2.mp3Loading ...
- Application
